CompuFlo Epidural System Will Unlock New Global Opportunities

Published
07 Apr 25
Updated
15 Aug 25
AnalystConsensusTarget's Fair Value
US$2.13
69.4% undervalued intrinsic discount
15 Aug
US$0.65
Loading
1Y
-33.2%
7D
1.6%

Author's Valuation

US$2.1

69.4% undervalued intrinsic discount

AnalystConsensusTarget Fair Value

Shared on01 May 25
Fair value Increased 1.67%

Shared on24 Apr 25

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on17 Apr 25
Fair value Increased 5.03%

AnalystConsensusTarget has increased revenue growth from 18.6% to 22.6%.

Shared on09 Apr 25
Fair value Decreased 6.35%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.